SpringerLink
Log in

Primärtherapie des Hodgkin-Lymphoms in frühen, intermediären und fortgeschrittenen Stadien

  • Leitthema
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Jones E, Mauch P (1996) Limited radiation therapy for selected patients with stages IA and IIA Hodgkin’s disease. Seminars in Radiation Oncology 6: 162–171

    Article  CAS  PubMed  Google Scholar 

  2. Biti G, Cimino G, Cartoni C, et al. (1992) Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hogkin’s disease: eight-year update of an Italian prospective randomized study. J Clin Oncol 10: 378–382

    Article  CAS  PubMed  Google Scholar 

  3. Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. J Am Med Assoc 270: 1949

    Article  CAS  Google Scholar 

  4. Ng AK, Bernardo P, Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch P (2002) Long-Term Survival and Competing Causes of Death in Patients with Early-Stage-Hodkgin’s Disease Treated at age 50 or younger. J Clin Oncol 20: 2101–2108

    Article  PubMed  Google Scholar 

  5. Aleman BMP, van den Belt-Dusebout AW, Klokman WJ, van’t Veer MB, Bartelink H, van Leeuwen FE (2003) Long-term cause-specific mortality of patients treated for Hodgkin’s Disease. J Clin Oncol 21: 3431–3439

    Article  PubMed  Google Scholar 

  6. Sieber M, Brillant C, Franklin J, Tesch H, Rueffer R, Herrmann R, Wieker K, Pfreundschuh M, Zschaber R, Wolf J, Paulus U, Loeffler M, Hasenclever D, Duehmke E, Engert A, Diehl V for the German Hodgkin’s Lymphoma Study Group (GHSG) (2003) Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin’s disease: Final results of the German Hodgkin’s Lymphoma Study Group trial HD7. ASH Abstract

  7. Zittoun R, Audebert A, Hoerni B, Bernadou A, Krulik M, Rojouan J, Eghbali H, Merle-Beral H, Parlier Y, Diebold J (1985) Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin‘s disease. J Clin Oncol 3: 207–214

    Article  CAS  PubMed  Google Scholar 

  8. Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, de Wit M, Mezger J, Dühmke E, Willich N, Müller RP, Schmidt BF, Renner H, Müller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Löffler M, Diehl V (2003) Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin’s Lymphoma: Results of the HD8 trial of the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 21: 3601–3608

    Article  PubMed  Google Scholar 

  9. Longo DL, Young RC, Wesley M, Hubbard M, Duffey PL, Jaffe ES, DeVita VT Jr (1986) Twenty years of MOPP chemotherapy for Hodgkin‘s disease. J Clin Oncol 4: 1295–1306

    Article  CAS  PubMed  Google Scholar 

  10. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin‘s disease with adriamycin, bleomycin, vinblastine, and imidazole carboximide versus MOPP. Cancer 36: 252–259

    Article  CAS  PubMed  Google Scholar 

  11. Santoro J, Bonadonna G, Valagussa P, et al. (1987) Long-term results of combined chemotherapy–radiotherapy approach in Hodgkin’s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5: 27

    Article  CAS  PubMed  Google Scholar 

  12. Canellos GP, Anderson JR, Propert KJ, et al. (1992) Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327

  13. Diehl V, Sieber M, Rüffer U, Lathan B, Hasenclever D, Pfreundschuh M, Loeffler M, Lieberz D, Koch P, Adler M, Tesch H, BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin‘s disease. Ann Oncol 8: 143–148

  14. Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U (2003) Hasenclever D, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. N Engl J Med 348: 2386–2395

    Article  CAS  PubMed  Google Scholar 

  15. Engert A, Pohl C, Diehl V (1992) Experimental therapy in Hodgkin’s disease. Ann Oncol 3 (Suppl 4): 97

    Article  PubMed  Google Scholar 

  16. Borchmann P, Schnell R, Fuss I, Manzke O, Davis T, Lewis L D, Behnke D, Wickenhauser C, Schiller P, Diehl V, Engert A (2002) Phase 1 trial of the novel bispecific molecule H22×Ki-4 in patients with refractory Hodgkin lymphoma. Blood 100: 3101–3107

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben

Author information

Authors and Affiliations

  1. Klinikum der Universität zu Köln, Germany

    K. Behringer, V. Diehl &  A. Engert

  2. Klinikum der Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Germany

    A. Engert

Authors
  1. K. Behringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Engert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Engert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behringer, K., Diehl, V. & Engert, A. Primärtherapie des Hodgkin-Lymphoms in frühen, intermediären und fortgeschrittenen Stadien. Onkologe 10 (Suppl 1), S38–S41 (2004). https://doi.org/10.1007/s00761-004-0658-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-004-0658-7

Search

Navigation